111 (NASDAQ:YI) Posts Earnings Results

111 (NASDAQ:YI) posted its earnings results on Friday, September 18th. The company reported ($0.60) earnings per share for the quarter, Zacks reports. The firm had revenue of $338.55 million for the quarter.

111 Stock Down 2.5%

YI opened at $2.90 on Friday. The stock’s fifty day moving average is $3.33 and its two-hundred day moving average is $5.05. The company has a market capitalization of $25.53 million, a P/E ratio of -1.82 and a beta of 0.67. 111 has a 52 week low of $2.48 and a 52 week high of $11.17.

Analysts Set New Price Targets

Separately, Weiss Ratings lowered shares of 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Tuesday, October 13th. One research analyst has rated the stock with a Sell rating. Based on data from MarketBeat, the stock presently has a consensus rating of “Sell”.

111 Company Profile

111, Inc is a China-based healthcare technology company that operates an online platform connecting consumers, pharmaceutical manufacturers, distributors and healthcare providers. The company focuses on improving access to medicines and health-related products through digital retail and supply-chain services.

Its business includes online sales of prescription and over-the-counter medicines, nutritional products, medical devices and other healthcare products. Through its technology platform, 111 also provides services intended to support pharmaceutical companies and pharmacies with product distribution, marketing, data and fulfillment.

Founded in 2010 and headquartered in Shanghai, 111 serves customers and healthcare businesses in China.